Strategic engagement offering, known as Inizio Engage, aims to simplify engagement opportunities across the product lifecycle.
Inizio, a partner for health and life sciences companies that assists with various services—including patient and engagement services across a drug’s lifecycle—is launching a new strategic combination at Inizio Engage. According to the company, it combines the expertise of Ashfield Engage and The Creative Engagement Group into a unified global strategic, commercial, and creative engagement partner.
Inizio Engage was formed in response to the rapidly evolving product and commercialization landscape in health and life sciences. Due to pricing pressures and fewer product approvals, companies are looking commercialize more efficiently and realize the promise of omnichannel engagements to reach and engage with disparate healthcare provider (HCP) and patient populations.
Essentially, the offering features analytics, technology, training, and delivery experience across health and life sciences to make sure that right message is delivered to the right person, at the right time, and in the right channel. Inizio Engage’s service offerings are grouped into five specialist areas:
Decision Optimization
XD (Experience Design)
Patient Solutions
Medical Affairs
Commercial
“Reaching HCPs and patients is getting more complex and challenging, due to seismic changes across the industry. That’s why we have decided to combine these two leading organizations together,” says Greg Flynn, global president, Inizio Engage. “By working as one, united, Inizio Engage brand, we can better leverage our respective talents and methodologies to create streamlined engagement opportunities across the product lifecycle, and power more effective engagement solutions. But more importantly, we empower our employees to share their passion and expertise in a broader context to deliver change in healthcare."
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.